Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: ANIP stock price vs TGNA: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TGNA's multiple
Needs TGNA P/E.
Implied fair value · at ANIP's multiple
Needs ANIP P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ANIP FY 2025 (ended Dec 31, 2025) · TGNA FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 84% equity / 16% debt · EV / Revenue 1.84x · EV / EBITDA 7.53x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ANI PHARMACEUTICALS, INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
TEGNA INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.57x
0.80x
Net debt / EBITDA
Leverage against operating earnings
0.11x
4.09x
Cash and equivalents
Liquid reserves on the balance sheet
$285.59M
$291.24M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SUPERNUS PHARMACEUTICALS, INC.
ANIP vs SUPN
PERRIGO Co plc
ANIP vs PRGO
Viatris Inc
ANIP vs VTRS
Organon & Co.
ANIP vs OGN
TEVA PHARMACEUTICAL INDUSTRIES LTD
ANIP vs TEVA
E.W. SCRIPPS Co
ANIP vs SSP
GRAY TELEVISION INC
ANIP vs GTN
NEXSTAR MEDIA GROUP, INC.
ANIP vs NXST
ENTRAVISION COMMUNICATIONS CORP
ANIP vs EVC
Fox Corp
ANIP vs FOXA
$309.11M
$2.53B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
